Sale!

SYNE1 Gene Emery-Dreifuss Muscular Dystrophy Type 4 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SYNE1 Gene Emery-Dreifuss Muscular Dystrophy Type 4 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the SYNE1 gene responsible for this rare form of muscular dystrophy. Using next-generation sequencing technology, this test provides precise detection of genetic variants that cause progressive muscle weakness, joint contractures, and cardiac complications. The test is essential for individuals experiencing early-onset muscle weakness, joint stiffness, or those with a family history of neuromuscular disorders. At only $500 USD, this advanced genetic analysis offers crucial information for accurate diagnosis, treatment planning, and family genetic counseling. Results are typically available within 3-4 weeks from blood or DNA samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SYNE1 Gene Emery-Dreifuss Muscular Dystrophy Type 4 NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Neuromuscular Disorders

The SYNE1 Gene Emery-Dreifuss Muscular Dystrophy Type 4 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare neuromuscular conditions. This advanced genetic analysis specifically targets mutations in the SYNE1 gene, which encodes nesprin-1 protein crucial for maintaining nuclear structure and function in muscle cells. When this gene malfunctions, it leads to progressive muscle degeneration, joint contractures, and potentially life-threatening cardiac complications.

What This Test Measures and Detects

Our state-of-the-art Next-Generation Sequencing (NGS) technology comprehensively analyzes the entire SYNE1 gene to identify:

  • Point mutations and single nucleotide variants
  • Insertions and deletions affecting gene function
  • Copy number variations and structural rearrangements
  • Pathogenic variants associated with Emery-Dreifuss Muscular Dystrophy Type 4
  • Novel mutations that may not be documented in existing databases

Who Should Consider This Genetic Test

This specialized genetic analysis is recommended for individuals presenting with:

  • Early-onset progressive muscle weakness, particularly in shoulders and upper arms
  • Joint contractures affecting elbows, ankles, and neck mobility
  • Cardiac conduction abnormalities or cardiomyopathy symptoms
  • Family history of neuromuscular disorders or sudden cardiac death
  • Unexplained elevated creatine kinase levels
  • Children or young adults with delayed motor development
  • Individuals with suspected autosomal recessive inheritance patterns

Key Benefits of SYNE1 Genetic Testing

  • Accurate Diagnosis: Provides definitive molecular confirmation of Emery-Dreifuss Muscular Dystrophy Type 4
  • Family Planning Guidance: Enables informed reproductive decisions and prenatal testing options
  • Personalized Treatment: Guides appropriate medical management and therapeutic interventions
  • Cardiac Monitoring: Identifies individuals requiring regular cardiac surveillance
  • Genetic Counseling: Supports comprehensive family risk assessment and education
  • Research Contribution: Helps expand understanding of rare neuromuscular conditions

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results:

  • Positive Result: Indicates the presence of pathogenic SYNE1 mutations confirming Emery-Dreifuss Muscular Dystrophy Type 4 diagnosis
  • Negative Result: Suggests absence of detectable SYNE1 mutations, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation and family studies
  • Carrier Status: Determines if individuals carry one copy of mutated gene without disease symptoms

All results are accompanied by detailed explanations and recommendations for next steps, including consultation with neurologists and genetic counselors.

Test Pricing and Availability

Test Component Price (USD)
SYNE1 Gene Emery-Dreifuss Muscular Dystrophy Type 4 NGS Genetic DNA Test $700
Discount Price $500

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Category: Neurological Disorders

Pre-Test Requirements

Before testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare provider
  • Informed consent for genetic analysis

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about neuromuscular symptoms affect your quality of life. Our SYNE1 genetic testing provides the clarity needed for proper diagnosis and management. With our discounted price of only $500, advanced genetic testing is more accessible than ever.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive answers about your neuromuscular health.

Our dedicated genetic specialists are available to answer your questions, explain the testing process, and help you understand how this comprehensive analysis can benefit you and your family. Early detection and accurate diagnosis are crucial for managing Emery-Dreifuss Muscular Dystrophy Type 4 effectively.